Published in Obstet Gynecol Int on September 26, 2013
Surgical treatment of endometrial cancer in developing countries: reasons to consider systematic two-step surgical treatment. Clinics (Sao Paulo) (2015) 0.79
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol (2005) 8.56
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol (2004) 8.29
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet (2008) 8.12
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet (2009) 6.98
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst (2008) 6.13
Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer (1987) 5.36
Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet (2010) 5.05
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol (2005) 4.95
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol (1991) 4.62
Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol (2008) 3.94
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol (2005) 3.31
Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 3.25
Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol (2011) 2.35
Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol (1995) 2.17
Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer (2012) 2.15
Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol (2012) 2.01
Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer (2006) 1.92
Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol (2006) 1.77
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol (2006) 1.75
Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol (2006) 1.63
The role of lymphadenectomy in endometrial cancer: was the ASTEC trial doomed by design and are we destined to repeat that mistake? Gynecol Oncol (2012) 1.56
Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol (2008) 1.54
Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol (2006) 1.54
The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol (2012) 1.52
Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration. Ann Oncol (2006) 1.49
Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol Oncol (2008) 1.47
Determinants of lymph node count in endometrial cancer surgical staging. Int J Gynecol Cancer (2012) 1.46
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol (2009) 1.35
Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol (1996) 1.33
The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecol Oncol (2007) 1.24
Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol (2005) 1.22
A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol (1997) 1.21
Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol (2010) 1.20
Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol (2004) 1.16
Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol (2011) 1.16
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer. Gynecol Oncol (2009) 1.15
Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev (2010) 1.13
Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer (2007) 1.11
Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol (2004) 1.11
Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol (2010) 1.11
Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol (1991) 1.10
The role of para-aortic lymphadenectomy in endometrial cancer. Int J Clin Oncol (2013) 1.07
Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev (2012) 1.02
Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol (2008) 1.01
A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy. Gynecol Oncol (2006) 1.01
Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique. Int J Gynecol Cancer (2011) 1.00
Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. Gynecol Oncol (2013) 0.99
ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol Oncol (2009) 0.98
Factors predictive of postoperative morbidity and cost in patients with endometrial cancer. Obstet Gynecol (2012) 0.98
Lymphoceles, lymphorrhea, and lymphedema after laparoscopic and open endometrial cancer staging. Ann Surg Oncol (2011) 0.96
Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol (2012) 0.93
Lymphadenectomy for endometrial cancer: the controversy. Gynecol Oncol (2010) 0.89
A new approach to label sentinel nodes in endometrial cancer. Gynecol Oncol (2007) 0.88
Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: a prospective study. Gynecol Oncol (2012) 0.87
The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol (2011) 0.86
Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol (1993) 0.86
Recurrence-free and 5-year survival following robotic-assisted surgical staging for endometrial carcinoma. Gynecol Oncol (2012) 0.86
The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol (2007) 0.86
Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer: a preliminary report. Gynecol Oncol (2012) 0.83
Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecol Oncol (2007) 0.82
Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol Oncol (2007) 0.81
Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients. Am J Obstet Gynecol (2006) 0.80
Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol (2009) 0.80
Intraoperative sentinel lymph node detection by vital dye through laparoscopy or laparotomy in early endometrial cancer. J Surg Oncol (2010) 0.79
Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer. Gynecol Oncol (2011) 0.79
Early stage endometrial cancer: to radiate or not to radiate--that is the question. Gynecol Oncol (2008) 0.78
[Clinical practice guideline: 2005 update of recommendations for the management of patients with cutaneous melanoma without distant metastases (summary report)]. Bull Cancer (2006) 0.76
Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting. Int J Gynecol Cancer (2013) 0.76
Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev Cell (2013) 1.89
The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levels. Cancer Prev Res (Phila) (2011) 1.85
Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet (2001) 1.70
Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. J Transl Med (2013) 1.43
Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients. Sci Transl Med (2014) 1.21
Objective and subjective cure rates after trans-obturator tape (OBTAPE) treatment of female urinary incontinence. Eur Urol (2005) 1.13
Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis. PLoS One (2011) 1.08
Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12. Int J Cancer (2011) 1.07
Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int J Cancer (2010) 1.03
Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties. PLoS One (2012) 0.99
Efficacy of selective arterial embolisation for the treatment of life-threatening post-partum haemorrhage in a large population. PLoS One (2008) 0.95
A French multicenter clinical trial of SPARC for stress urinary incontinence. Eur Urol (2003) 0.95
Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model. J Transl Med (2013) 0.94
Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses. Int J Cancer (2010) 0.91
Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes. PLoS One (2013) 0.90
Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis. J Transl Med (2012) 0.90
Oncologic trogocytosis with Hospicells induces the expression of N-cadherin by breast cancer cells. Int J Oncol (2010) 0.87
Microparticles mediated cross-talk between tumoral and endothelial cells promote the constitution of a pro-metastatic vascular niche through Arf6 up regulation. Cancer Microenviron (2014) 0.87
Endothelial cells provide a niche for placental hematopoietic stem/progenitor cell expansion through broad transcriptomic modification. Stem Cell Res (2013) 0.87
Vaginal mesh erosion 7 years after a sacral colpopexy. Acta Obstet Gynecol Scand (2003) 0.87
Role of the microenvironment in ovarian cancer stem cell maintenance. Biomed Res Int (2012) 0.85
Pelvic lymph node dissection via a lateral extraperitoneal approach: description of a technique. Gynecol Oncol (2008) 0.84
Adaptation of a commonly used, chemically defined medium for human embryonic stem cells to stable isotope labeling with amino acids in cell culture. J Proteome Res (2013) 0.83
Morbidity of vaginal hysterectomy for benign tumors as a function of uterine weight. J Reprod Med (2003) 0.82
Sigmoid endometriosis in a postmenopausal woman. Am J Obstet Gynecol (2002) 0.81
Sonography in prenatal diagnosis of congenital adrenal hyperplasia. Prenat Diagn (2004) 0.79
[Preservation of fertility in gynaecologic cancers]. Bull Cancer (2008) 0.79
The Necessity of a Systematic Approach for the Use of MSCs in the Clinical Setting. Stem Cells Int (2013) 0.78
[Critical study of our initial experience of 993 sentinel node biopsies for breast surgery]. Bull Cancer (2008) 0.77
Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting. Int J Gynecol Cancer (2013) 0.76
Pitfalls of CA-125 levels in the preoperative work-up of ovarian masses. J Clin Oncol (2008) 0.75
Circulating tumor DNA as a prognostic factor. Am J Obstet Gynecol (2006) 0.75
Correction: Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian Cancer. PLoS Genet (2016) 0.75
Randomized study of aggressive surgery for advanced ovarian cancer. Int J Gynecol Cancer (2013) 0.75
[Laparoscopic surgery and gynaecological cancers]. Bull Cancer (2007) 0.75
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery. Int J Gynecol Cancer (2016) 0.75